4.6 Article

Tongue Force Analysis Assesses Motor Phenotype in Premanifest and Symptomatic Huntington's Disease

期刊

MOVEMENT DISORDERS
卷 25, 期 13, 页码 2195-2202

出版社

WILEY-BLACKWELL
DOI: 10.1002/mds.23243

关键词

Huntington's disease; chorea; motor control; basal ganglia

资金

  1. University of Munster, Germany [RE-120225]
  2. Cure Huntington's Disease Initiative-Foundation (CHDI), New York, USA
  3. European Huntington's Disease Network (EHDN-www.euro-hd.net), Ulm, Germany
  4. Neurosearch Inc., Denmark
  5. Medivation/Pfizer
  6. High-Q-Foundation
  7. Cure Huntington's Disease Initiative Foundation
  8. European Huntington's Disease Network (EHDN)

向作者/读者索取更多资源

Motor symptoms in Huntington's Disease (HD) are commonly assessed by the Unified Huntington's Disease Rating Scale-Total Motor Score (UHDRS-TMS). However, the UHDRS-TMS is limited by interrater variability, its categorical nature, and insensitivity in premanifest subjects. More objective and quantitative measures of motor phenotype may complement the use of the UHDRS-TMS as outcome measure and increase the power and sensitivity of clinical trials. Deficits in tongue protrusion are well acknowledged in HD and constitute a subitem of the UHDRS-TMS. We, therefore, investigated whether objective and quantitative assessment of tongue protrusion forces (TPF) provides measures that (1) correlate to the severity of motor phenotype detected in the UHDRS-TMS in symptomatic HD, (2) detect a motor phenotype in premanifest HD gene-carriers, and (3) exhibit a correlation to the genotype as assessed by a disease burden score (based on CAG-repeat length and age). Using a precalibrated force transducer, the ability of premanifest gene carriers (n = 15) and subjects with symptomatic HD (n = 20) to generate and maintain isometric TPF at three target force levels (0.25, 0.5, and 1.0 N) was assessed and compared with age-matched controls (n - 20) in a cross-sectional study. Measures of variability of TPF and tongue contact time distinguished controls, premanifest, and symptomatic HD groups and correlated to the UHDRS-TMS and disease burden score, suggesting a strong genotype-phenotype correlation. Group distinction was most reliable at the lowest target force level. We conclude that assessment of TPF may be a useful objective and quantitative marker of motor dysfunction in premanifest and symptomatic HD. (C) 2010 Movement Disorder Society

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据